Back to search

Article

Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure

2017-09-05

Abstract excerpt

The US FDA defines modified risk tobacco products (MRTPs) as products that aim to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products.  Establishing a product’s potential as an MRTP requires scientific substantiation including toxicity studies and measures of disease risk relative to those of cigarette smoking.  Best practices encourage verification of the data...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5862657b-1797-5abd-ac05-1090e9ee3aaa
DOI
10.12688/f1000research.10493.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructureDOI 10.12688/f1000research.10493.2
Select a neighboring publication to make it the new centre.